by el magnifico on Tue Dec 02, 2008 3:07 am Nor is it for men who cialis levitra sales viagra suffered a recent heart attack or stroke who have very low blood pressure or uncontrolled high blood pressure. The FDA said Levitra should never be used by men who: Take nitrate-containing drugs for heart conditions. Men are advised to get a thorough physical exam cialis levitra sales viagra before using Levitra for the first time, the FDA said. GSK says that 30 million men in the US alone suffer from some form of impotence, with only a fraction seeking treatment. Cialis held 27% of the US market, with sales up 26% to $294 cialis levitra sales viagra million, while Levitra claimed 13. 3% with cialis levitra sales viagra sales up 30% to $144 million. GSK and Bayer will continue to co-market Levitra in the US, where television and poster advertising of prescription drugs is allowed and where GSK believes a big marketing push could improve sales.
GSK will market Levitra with Bayer, the German drugs giant which originally developed the drug. Viagra leads outside the cialis levitra sales viagra us, with 49. 3% of the market, while cialis levitra sales viagra levitra boasts 15. 3% share, Lilly said. For otherwise healthy men, Levitra's main side effects were headache, flushing and a stuffy nose.
Scope of this title: * Patient potential, unmet needs and epidemiological trends in erectile dysfunction * Pipeline overview including key company players, product profiles, and pipeline issues * Case study analysis of market leaving brands: Pfizers Viagra; ICOS-Lillys Cialis; and Bayer/Schering-Plough/GlaxoSmithKlines Levitra * Analysis of the future direction of the market as supported by the views of interviewed key international opinion leaders Highlights of this title: * PDE-5 inhibitors Cialis levitra sales viagra will remain the mainstay of ED treatment, having an excellent efficacy and safety profile. Made the pill one of the nation's Cialis levitra sales viagra most heavily promoted drugs, spending $101 million on marketing in 2001 alone. The company is trying to strengthen its pharmaceuticals business after losing sales of its best-selling medicine, the antibiotic Cipro. -- also has European approval and is expected to hit U.
The UK's biggest drug maker yesterday sold European and cialis levitra sales viagra other rights to the product back to its inventor, Bayer of Germany, for EUR208m (pounds 145m). About 2 percent became Cialis levitra sales viagra dizzy. The erectile dysfunction market grew 3. 5% from 2005 to be worth $1. 95 billion in 2005 and is almost entirely composed of sales from three brands: Viagra (sildenafil), Cialis (tadalafil) and Levitra (vardenafil). Levitra is the second cialis levitra sales viagra rival to Viagra to be launched this year. Sales of Viagra, which hit the market cialis levitra sales viagra in 1998, totaled $1.7 billion last cialis levitra sales viagra year.
montazemi | Sunday 2nd August 2009 02:36:03 PM
In terms of new mechanisms of action, opinion leaders are unconvinced by what is in the current pipeline.
mitch | Thursday 13th August 2009 07:12:37 AM
The Food and Drug cialis levitra sales viagra administration approved Levitra Tuesday.
laba | Friday 14th August 2009 05:13:38 PM
Levitra was launched in 2003 but has failed to capture sales from the iconic blue pill which turned male impotence into a multibillion- dollar drug market in the 1990s.
anja | Monday 24th August 2009 11:06:05 PM
Until now, the blue, diamond-shaped Viagra pills have been the only oral prescription drug available for an estimated 30 million Cialis levitra sales viagra american men who suffer some degree of impotence -- most of whom don't seek medical therapy.
cofi | Friday 14th August 2009 10:10:40 PM
New PDE-5 inhibitors need a unique clinical advantage to Cialis levitra sales viagra compete with the established products.sam | Sunday 16th August 2009 10:38:41 AM
Analysts, however, have speculated that Levitra may not be able to hold on to that market share, especially in light of more competition in the erectile dysfunction market, namely Eli Lilly's Cialis, that's expected in the coming months.
WASHINGTON -- The government has approved the sale of a second pill to treat erectile dysfunction, setting the stage for a fierce battle with Viagra in the billion-dollar-plus impotence market.